MIRA Pharmaceuticals Stock
MIRA Pharmaceuticals, Inc.
Company data
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Country
- United States
- CEO
- Erez Aminov
- Employees
- 2
- Market cap
- $27 M
- IPO
- 03/08/2023
MIRA Pharmaceuticals, Inc. operates as a biopharmaceutical enterprise currently in the clinical development phase. Its main objective involves the creation and market introduction of a novel synthetic tetrahydrocannabinol (THC) analog. This compound is undergoing investigation for its potential to address anxiety and…
MIRA Pharmaceuticals stock: price history
1D
-3.9%
1W
-15.2%
1M
-12.1%
6M
-40.3%
YTD
-58.1%
1Y
-64.9%
2Y
-42.5%
5Y
–
10Y
–
Next earnings date
Next earnings date
02/12/2026 (in 46 days)
Volatility around earnings
~16% weaker price swings than usual
Ask the agents about MIRA Pharmaceuticals
Analyst assessment of MIRA Pharmaceuticals
0
STRONG BUY
2
BUY
0
HOLD
0
SELL
0
STRONG SELL
2
TOTAL · Buy
No current analyst ratings available.
MIRA Pharmaceuticals stock metrics
P/E
-0.46
P/B
3.26
EV/EBITDA
-2.44
RETURN ON EQUITY
-14.8%
NET MARGIN
0.0%
DEBT/EQUITY
0
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
63.9%
FLOAT SHARES
26,863,286
AVG. DAILY VOLUME (30D)
157,074
Institutional holders
Comparable stocks
Frequently asked questions about MIRA Pharmaceuticals stock
What does MIRA Pharmaceuticals do?
MIRA Pharmaceuticals, Inc. is a company in the Healthcare sector, Drug Manufacturers - General industry, headquartered in United States.
The CEO is Erez Aminov, the company employs around 2 people.
The IPO was on 03/08/2023; the stock trades on NASDAQ under the ticker MIRA.
When does MIRA Pharmaceuticals report next?
The next earnings date is 02/12/2026.
Around past earnings, price swings were roughly -16% stronger than usual.
Does MIRA Pharmaceuticals pay a dividend?
No, MIRA Pharmaceuticals currently does not pay a dividend.
Which stocks are comparable to MIRA Pharmaceuticals?
Comparable stocks include Eli Lilly and Company, Johnson & Johnson, AbbVie, Merck &, Amgen, Gilead Sciences, Pfizer and Bristol-Myers Squibb Company.
How can I get MIRA Pharmaceuticals stock analyzed?
Clicking "Analyze stock" lets five strategies assess MIRA Pharmaceuticals against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.